Development and initial validation of a multivariable predictive Early Adversity Scale for Schizophrenia (EAS-Sz) using register data to quantify environmental risk for adult schizophrenia diagnosis after childhood exposure to adversity.

Childhood adversity epidemiology prediction psychosis ranking risk scale schizophrenia

Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
08 2023
Historique:
medline: 1 9 2023
pubmed: 12 7 2022
entrez: 11 7 2022
Statut: ppublish

Résumé

Additional to a child's genetic inheritance, environmental exposures are associated with schizophrenia. Many are broadly described as childhood adversity; modelling the combined impact of these is complex. We aimed to develop and validate a scale on childhood adversity, independent of genetic and other environmental liabilities, for use in schizophrenia risk analysis models, using data from cross-linked electronic health and social services registers. A cohort of A weighted combination of 42 measures of childhood adversity was derived from the development sample. Independent application to identical measures in validation samples produced Harrell's Concordance statistics of 0.656 and 0.624. Average predicted time to diagnosis curves corresponded with 95% CI limits of observed Kaplan-Meier curves in five prognostic categories. Our Early Adversity Scale for Schizophrenia (EAS-Sz), the first using routinely collected register data, predicts schizophrenia diagnosis above chance, and has potential to help untangle contributions of genetic and environmental liability to schizophrenia risk.

Sections du résumé

BACKGROUND
Additional to a child's genetic inheritance, environmental exposures are associated with schizophrenia. Many are broadly described as childhood adversity; modelling the combined impact of these is complex. We aimed to develop and validate a scale on childhood adversity, independent of genetic and other environmental liabilities, for use in schizophrenia risk analysis models, using data from cross-linked electronic health and social services registers.
METHOD
A cohort of
RESULTS
A weighted combination of 42 measures of childhood adversity was derived from the development sample. Independent application to identical measures in validation samples produced Harrell's Concordance statistics of 0.656 and 0.624. Average predicted time to diagnosis curves corresponded with 95% CI limits of observed Kaplan-Meier curves in five prognostic categories.
CONCLUSIONS
Our Early Adversity Scale for Schizophrenia (EAS-Sz), the first using routinely collected register data, predicts schizophrenia diagnosis above chance, and has potential to help untangle contributions of genetic and environmental liability to schizophrenia risk.

Identifiants

pubmed: 35817425
doi: 10.1017/S0033291722001945
pii: S0033291722001945
pmc: PMC10476059
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4990-5000

Références

Schizophr Bull. 2016 Sep;42(5):1262-9
pubmed: 26884547
Am J Psychiatry. 2018 Dec 1;175(12):1232-1242
pubmed: 30278792
Nature. 2010 Nov 11;468(7321):203-12
pubmed: 21068828
Schizophr Res. 2018 Feb;192:465-466
pubmed: 28427931
Am J Psychiatry. 2010 Oct;167(10):1240-6
pubmed: 20686186
PLoS One. 2014 Nov 21;9(11):e113677
pubmed: 25415265
Schizophr Bull. 2017 Oct 21;43(6):1190-1196
pubmed: 28981842
Acta Psychiatr Scand. 2005 Nov;112(5):330-50
pubmed: 16223421
Mol Psychiatry. 1999 Mar;4(2):163-72
pubmed: 10208448
Psychol Bull. 2013 Nov;139(6):1342-96
pubmed: 23566018
Br J Psychiatry. 2010 Sep;197(3):207-11
pubmed: 20807965
Schizophr Bull. 2012 Jun;38(4):661-71
pubmed: 22461484
Lancet. 2016 Jul 2;388(10039):86-97
pubmed: 26777917
JAMA Psychiatry. 2018 Oct 1;75(10):985-986
pubmed: 29874362
Arch Gen Psychiatry. 2010 Feb;67(2):113-23
pubmed: 20124111
Am J Psychiatry. 2002 Jul;159(7):1080-92
pubmed: 12091183
Psychol Med. 2015 Jul;45(9):1789-98
pubmed: 25402968
JAMA. 1982 May 14;247(18):2543-6
pubmed: 7069920
Br J Psychiatry. 2010 Nov;197(5):378-85
pubmed: 21037215
Schizophr Bull. 2012 Nov;38(6):1118-23
pubmed: 23015685
World Psychiatry. 2016 Jun;15(2):93-102
pubmed: 27265690
Psychol Med. 2015 Oct;45(13):2825-37
pubmed: 25952483
Aust N Z J Psychiatry. 2019 Nov;53(11):1105-1115
pubmed: 31339337
Int J Epidemiol. 2011 Dec;40(6):1477-85
pubmed: 20870781
Psychol Med. 2007 Apr;37(4):495-503
pubmed: 17094816
Psychol Med. 2020 Oct;50(13):2213-2220
pubmed: 31535606
Psychol Med. 2008 Dec;38(12):1701-15
pubmed: 19000327
Schizophr Res. 2001 Aug 1;51(1):93-102
pubmed: 11479071
Schizophr Bull. 2021 Mar 16;47(2):277-283
pubmed: 33215211
Australas Psychiatry. 2018 Jun;26(3):290-293
pubmed: 28691522
Am J Psychiatry. 2005 Sep;162(9):1652-7
pubmed: 16135624
Schizophr Bull. 2015 Mar;41(2):346-54
pubmed: 24903417
JAMA Psychiatry. 2013 Apr;70(4):427-35
pubmed: 23446644
Schizophr Res. 2017 Mar;181:17-22
pubmed: 28029515
Schizophr Bull. 1987;13(1):23-47
pubmed: 3474774
Child Abuse Negl. 2004 Jul;28(7):771-84
pubmed: 15261471
Schizophr Bull. 2010 Jul;36(4):655-64
pubmed: 20513653
Schizophr Bull. 2019 Sep 11;45(5):960-965
pubmed: 31508804
Clin Genet. 1994 Jul;46(1 Spec No):116-23
pubmed: 7988068

Auteurs

Patsy Di Prinzio (P)

Neuropsychiatric Epidemiology Research Unit, School of Population and Global Health, The University of Western Australia, Perth, Australia.

Jonas Björk (J)

Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden.

Giulietta Valuri (G)

School of Population and Global Health, The University of Western Australia, Perth, Australia.

Taryn Ambrosi (T)

Neuropsychiatric Epidemiology Research Unit, School of Population and Global Health, The University of Western Australia, Perth, Australia.

Maxine Croft (M)

Neuropsychiatric Epidemiology Research Unit, School of Population and Global Health, The University of Western Australia, Perth, Australia.

Vera A Morgan (VA)

Neuropsychiatric Epidemiology Research Unit, School of Population and Global Health, The University of Western Australia, Perth, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH